# OnCo record paper-dangelo-mucosal-melanoma-pooled-jco-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-dangelo-mucosal-melanoma-pooled-jco-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-dangelo-mucosal-melanoma-pooled-jco-2017" ;
  schema:name "Nivolumab alone or with ipilimumab in mucosal melanoma: pooled analysis"@en ;
  schema:description "Pooling several trials showed that mucosal melanoma responds to nivolumab less often than skin melanoma, but that adding ipilimumab raised the response rate from about a quarter to more than a third, supporting combination immunotherapy first."@en ;
  schema:url <https://onco.cc/key-papers/paper-dangelo-mucosal-melanoma-pooled-jco-2017/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2016.67.9258>, <https://pubmed.ncbi.nlm.nih.gov/28056206/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2016.67.9258> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "D'Angelo SP, Larkin J, Sosman JA, et al." ;
  onco:cancers <https://onco.cc/cancers/mucosal-melanoma/> ;
  onco:drugs <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:journals <https://onco.cc/journals/jco/> .